Literature DB >> 26121596

Canadian Stroke Best Practice Recommendations: Mood, Cognition and Fatigue Following Stroke practice guidelines, update 2015.

Gail A Eskes1, Krista L Lanctôt2,3, Nathan Herrmann2,3, Patrice Lindsay3,4, Mark Bayley3,5, Laurie Bouvier6, Deirdre Dawson7, Sandra Egi8, Elizabeth Gilchrist9, Theresa Green10, Gord Gubitz11, Michael D Hill12, Tammy Hopper13, Aisha Khan14, Andrea King15, Adam Kirton16, Paige Moorhouse15, Eric E Smith12, Janet Green1, Norine Foley17, Katherine Salter17, Richard H Swartz2,3.   

Abstract

Every year, approximately 62 000 people with stroke and transient ischemic attack are treated in Canadian hospitals, and the evidence suggests one-third or more will experience vascular-cognitive impairment, and/or intractable fatigue, either alone or in combination. The 2015 update of the Canadian Stroke Best Practice Recommendations: Mood, Cognition and Fatigue Module guideline is a comprehensive summary of current evidence-based recommendations for clinicians in a range of settings, who provide care to patients following stroke. The three consequences of stroke that are the focus of the this guideline (poststroke depression, vascular cognitive impairment, and fatigue) have high incidence rates and significant impact on the lives of people who have had a stroke, impede recovery, and result in worse long-term outcomes. Significant practice variations and gaps in the research evidence have been reported for initial screening and in-depth assessment of stroke patients for these conditions. Also of concern, an increased number of family members and informal caregivers may also experience depressive symptoms in the poststroke recovery phase which further impact patient recovery. These factors emphasize the need for a system of care that ensures screening occurs as a standard and consistent component of clinical practice across settings as stroke patients transition from acute care to active rehabilitation and reintegration into their community. Additionally, building system capacity to ensure access to appropriate specialists for treatment and ongoing management of stroke survivors with these conditions is another great challenge.
© 2015 World Stroke Organization.

Entities:  

Keywords:  depression; fatigue; guidelines; stroke; transient ischemic attack; vascular cognitive impairment

Mesh:

Year:  2015        PMID: 26121596     DOI: 10.1111/ijs.12557

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  22 in total

Review 1.  Diagnostic test accuracy of the Montreal Cognitive Assessment in the detection of post-stroke cognitive impairment under different stages and cutoffs: a systematic review and meta-analysis.

Authors:  Dan Shi; Xiao Chen; Zheng Li
Journal:  Neurol Sci       Date:  2018-02-09       Impact factor: 3.307

2.  Sample sizes and precision of estimates of sensitivity and specificity from primary studies on the diagnostic accuracy of depression screening tools: a survey of recently published studies.

Authors:  Brett D Thombs; Danielle B Rice
Journal:  Int J Methods Psychiatr Res       Date:  2016-04-08       Impact factor: 4.035

3.  Influence of Medication on Fatigue Six Months after Stroke.

Authors:  Amélie Ponchel; Julien Labreuche; Stéphanie Bombois; Christine Delmaire; Régis Bordet; Hilde Hénon
Journal:  Stroke Res Treat       Date:  2016-06-19

4.  Risk of Bias from Inclusion of Currently Diagnosed or Treated Patients in Studies of Depression Screening Tool Accuracy: A Cross-Sectional Analysis of Recently Published Primary Studies and Meta-Analyses.

Authors:  Danielle B Rice; Brett D Thombs
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

5.  Racial Disparity in Stroke Awareness in the US: An Analysis of the 2014 National Health Interview Survey.

Authors:  Nwakile Ojike; Joe Ravenell; Azizi Seixas; Alina Masters-Israilov; April Rogers; Girardin Jean-Louis; Gbenga Ogedegbe; Samy I McFarlane
Journal:  J Neurol Neurophysiol       Date:  2016-04-07

6.  Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments meta-analysis.

Authors:  Yefei Sun; Yifan Liang; Yang Jiao; Jueying Lin; Huiling Qu; Junjie Xu; Chuansheng Zhao
Journal:  BMJ Open       Date:  2017-08-03       Impact factor: 2.692

7.  Therapeutic Strategies and Drug Development for Vascular Cognitive Impairment.

Authors:  Eric E Smith; Alicja Cieslak; Philip Barber; Jerry Chen; Yu-Wei Chen; Ida Donnini; Jodi D Edwards; Richard Frayne; Thalia S Field; Janka Hegedus; Victoria Hanganu; Zahinoor Ismail; Jamila Kanji; Makoto Nakajima; Raza Noor; Stefano Peca; Demetrios Sahlas; Mukul Sharma; Luciano A Sposato; Richard H Swartz; Charlotte Zerna; Sandra E Black; Vladimir Hachinski
Journal:  J Am Heart Assoc       Date:  2017-05-05       Impact factor: 5.501

8.  The "DOC" screen: Feasible and valid screening for depression, Obstructive Sleep Apnea (OSA) and cognitive impairment in stroke prevention clinics.

Authors:  Richard H Swartz; Megan L Cayley; Krista L Lanctôt; Brian J Murray; Ashley Cohen; Kevin E Thorpe; Michelle N Sicard; Karen Lien; Demetrios J Sahlas; Nathan Herrmann
Journal:  PLoS One       Date:  2017-04-04       Impact factor: 3.240

9.  Post-stroke fatigue: A factor associated with inability to return to work in patients <60 years-A 1-year follow-up.

Authors:  Nicole Anna Rutkowski; Elham Sabri; Christine Yang
Journal:  PLoS One       Date:  2021-08-04       Impact factor: 3.240

10.  An exploration into caring for a stroke-survivor in Lima, Peru: Emotional impact, stress factors, coping mechanisms and unmet needs of informal caregivers.

Authors:  M Amalia Pesantes; Lena R Brandt; Alessandra Ipince; J Jaime Miranda; Francisco Diez-Canseco
Journal:  eNeurologicalSci       Date:  2016-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.